Background: Transforming growth factor β 1 (TGFβ 1 ) is a potent inhibitor of epithelial cell growth, thus playing an important role in tissue homeostasis. Most carcinoma cells exhibit a reduced sensitivity for TGFβ 1 mediated growth inhibition, suggesting TGFβ 1 participation in the development of these cancers. The tumor suppresor gene DPC4/SMAD4, which is frequently inactivated in carcinoma cells, has been described as a key player in TGFβ 1 mediated growth inhibition. However, some carcinoma cells lacking functional SMAD4 are sensitive to TGFβ 1 induced growth inhibition, thus requiring a SMAD4 independent TGFβ 1 pathway.
Background
The normal function of transforming growth factor β 1 (TGFβ 1 ) is essential for the entire organism, representing a multifunctional regulator of cell growth and differentiation [1] [2] [3] [4] [5] . TGFβ 1 is a potent inhibitor of epithelial cell proliferation. Upon binding of TGFβ 1 , TGFβ 1 -receptors phosphorylate SMAD2 or SMAD3 [6] [7] [8] [9] [10] [11] [12] . Phosphorylated SMAD2/3 associates with SMAD4 and, as a complex, moves into the nucleus, where it regulates gene expression [13] [14] [15] . SMAD4 (DPC4) is essential for this TGFβ 1 signaling and transcriptional activation process [16] . In epithelial cells, TGFβ 1 decreases c-myc, cdc2 and cyclin D1 expression, and it increases the expression of c-jun and c-fos [17] [18] [19] [20] [21] [22] [23] . Activation of the TGFβ 1 signal pathway in epithelial cells leads to an increased expression of the cell cycle inhibitors p21 WAF1 and p15 Ink4b and to a release of formerly sequestered p27 KIP [24] [25] [26] . It is assumed that the cooperative action of these cell cycle inhibitors results in the growth arrest mentioned above, although p15 Ink4b does not seem to be necessary in this regard. In addition to mutations in the TGFβ 1 -receptors, in a large number of carcinomas disruptions of this signaling pathway by the alteration of a single protein such as p15 Ink4b , p16, and p21 Waf1 are found [2, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . This may result in resistance to the growth-inhibiting action of TGFβ 1 .
In several cell lines, particularly in pancreatic carcinoma cells, resistance to TGFβ 1 could be attributed to a loss of function of the SMAD4 (DPC4) protein [40] [41] [42] [43] . However, the pancreatic carcinoma cell line BxPC-3, although homozygously deleted for SMAD4, is growth inhibited by TGFβ 1 [30, 44] . It is thus speculated that alternative signaling pathways in addition to the SMAD pathway may exist.
After binding to α V β 6 integrin, latent TGFβ 1 is activated by processing of latent TGFβ 1 by cleavage of the latency-associated Peptide (LAP) [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] . Recently, the interaction of latent TGFβ 1 with α V β 6 integrin has been shown [45] . After binding of latent TGFβ 1 to α V β 6 integrin, latent TGFβ 1 is activated by cleavage of the latency-associated peptide (LAP) [45] . This α V β 6 integrin is also expressed by pancreatic carcinoma cells [58] [59] [60] [61] [62] [63] . We hypothesized that there is a SMAD-independent TGFβ 1 signaling pathway in TGFβ 1 -sensitive carcinoma cells. To address this question, several carcinoma cell lines with different degrees of TGFβ 1 sensitivity were chosen as a model system. We investigated the interaction of TGFβ 1 with the α V β 6 integrin and its influence on selected target genes known to be involved in cell cycle-regulated growth inhibition. Here, we demonstrate an alternate TGFβ 1 signaling pathway via α V β 6 integrin contributing to TGFβ 1 growth inhibiton in TGFβ 1 sensitive carcinoma cells.
Results

Mature TGFβ 1 induces cytoskeletal immobilization of
proteins and tyrosine phosphorylation via integrin α V β 6 only in TGFβ 1 sensitive cells Only integrins that have bound their ligands are anchored to the cytoskeleton [64, 65] . In our experiments, mature TGFβ 1 , α V β 6 integrin, and F-actin colocalize (Figure 1 ), suggesting association with and activation of this integrin. To further support this finding, we stimulated cells and performed co-immunoprecipitated various integrin subunits of cytoskeletal anchored proteins [66, 67] (additional file 1, 2, 3 and 4). Our data strongly suggest that mature TGFβ 1 associates with α V β 6 integrin (additional file 1, 2, 3 and 4).
To determine whether binding of mature TGFβ 1 leads to integrin-mediated signaling, we looked at the status of integrin-cytoskeleton-associated proteins [66, 67] after incubation with mature TGFβ 1 in selected carcinoma cell lines with different degrees of sensitivity to TGFβ 1 (Table  1) . Cytoskeletal anchored proteins were precipitated with anti α V and β 6 -antibodies. Immobilization of proteins to the cytoskeleton (Triton-X insoluble fraction, Figure 2B ) as well as tyrosine phosphorylation of these proteins (Figure 2A ) induced through mature TGFβ 1 was only seen in the TGFβ 1 -sensitive carcinoma cell lines (Figure 2 and additional file 5). Notably, tyrosine phosphorylation of cytoskeletally anchored proteins is further enhanced after combined treatment with mature TGFβ 1 and fibronectin in TGFβ 1 sensitive cells ( Figure 3 ). In contrast, in the TGFβ 1 -resistant AsPC-1 and Capan-1 cells, the interaction of mature TGFβ 1 with α V β 6 integrin resulted in an immobilization of high molecular weight proteins to the cytoskeleton without tyrosine phosphorylation ( Figure  2 ). Again, stimulation of TGFβ 1 sensitive cells BxPC-3, LoVo [68] , SW48 [68] , Keratinocytes, HeLa and DLD1 [69] , results in an enhanced cytoskeletal immobilization and tyrosine phosphorylation of cellular proteins in response to stimulation with mature TGFβ 1 (additional file 5). Remarkably, preincubation with the MEK1 inhibitor PD98059 resulted in a reduced cytoskeletal immobilization and tyrosine phosphorylation of cellular proteins in response to stimulation with mature TGFβ 1 . This finding is in agreement with other observations that MEK1-mediated signal transduction is involved in cytoskeletal remodeling and integrin engagement [70, 71] .
Activation of p125 FAK , a central step in integrin-associated signaling [72, 73] , was determined to assess integrin-mediated signaling. BcPC-3 cells are sensitive to TGFβ 1 but are SMAD4 deleted. We incubated BxPC-3 cells with mature TGFβ 1 and observed an association on the cytoskeleton connected with integrin α V β 6 and activation of p125 FAK (Figure 4 ). Indeed, TGFβ 1 antibodies, cytochalasin D and BAPTA-AM [66] abolished the association on the cytoskeleton connected with integrin α V β 6 and activation of p125 FAK . These data further suggest that TGFβ 1 mediated activation of p125 FAK depends on free intracellular calcium and an intact actin cytoskeleton.
In order to test whether TGFβ 1 signaling via α V β 6 is specific for SMAD4 deleted BxPC-3 cells or if this is a general phenomenon, we investigated signaling in TGFβ 1 -sensitive carcinoma cell lines HeLa, MCF-7 and MDA-MB-231. TGFβ 1 induced recruitment of p125 Fak , p130 Cas and Sos1/ 2 to the cytoskeleton. Enhanced expression of c-jun, c-fos, p21 WAF1 and p27 KIP , while downregulating PCNA, is dependent on ERK1/2 signaling, an intact cytoskeleton and intracellular calcium ( Figures 5, 6A , 7, 8 and additional files 6, 7 and 8). We also confirmed the purity of the commercially available mature TGFβ 1 used in these experiments by silver stained non-reducing SDS-PAGE, with latent TGFβ 1 as control ( Figure 6B ). We also demonstrated the SMAD4 deficiency of the BxPC-3 cells used ( Figure  6C ). To exclude this possibility, cellular proteins were divided into cytoplasmatic and nuclear fractions after TGFβ 1 stimulation, and localization and phosphorylation of SMAD2/3 were investigated. In the SMAD4 deleted BxPC-3 cells, TGFβ 1 resulted in phosphorylation of SMAD2/3, but the activated SMAD proteins were retained in the cytoplasmatic fraction ( Figure 9 ). Remarkably, in NP-9 cells [74] , SMAD2/3 are translocated into the nucleus upon TGFβ 1 stimulation (additional file 9(A)) but we could not observe an enhanced tyrosine phosphorylation of cytoskeletal anchored proteins (additional file 9(B)). 
Discussion
A recent study demonstrated an interaction of latent TGFβ 1 with α V β 6 integrin, which led to an activation of latent TGFβ 1 [45] . Incubation of different tumor cells with mature TGFβ 1 resulted in a direct binding of TGFβ 1 to α V β 6 integrin. Certain integrins appear to be preferentially associated with specific growth factor receptors [80] . The interaction of these two receptor classes seems to take place via the actin cytoskeleton. We were able to exclude such signal pathway association, since in our cytoskeletal preparations, no TGFβ 1 -receptors were detectable, indicating that mature TGFβ 1 is a ligand for α V β 6 .
It has been reported that activated integrins are associated with the cytoskeleton. Here, we show that binding of mature TGFβ 1 to α V β 6 integrin resulted in an association of the cytoskeleton ( Figure 10 ). In a variety of integrinmediated signaling pathways, tyrosinephosphorylation of proteins immobilized to the cytoskeleton is enhanced [66, 67] . The same was true in our experimental settings only for the TGFβ 1 -sensitive cells. This upregulation of Phosphorylation and immobilization of proteins associated with the integrin-cytoskeleton-complex Figure 2 Phosphorylation and immobilization of proteins associated with the integrin-cytoskeleton-complex.
Cytoskeletally anchored α V β 6 was immunoprecipitated after TGFβ 1 stimulation (10 nM for 10 minutes) followed by Western analysis with antibodies against tyrosine-phosphorylated proteins (A) or Western blotting after biotinylation of all proteins and streptavidin detection (B). Presence of TGFβ 1 (C), α V and β 6 integrin (D) in the co-precipitates is also demonstrated. TGFβ-receptor-I and II (TGFβRI and TGFβRII) are expressed at nearly equal levels in all cell lines as demonstrated by western blotting from whole cell extracts (E). In part the cells were preincubated with α V -and β 6 -antibodies (1:100 each for 30 min) or with a TGFβ antibody (15 µg/ml for 30 min). Binding of mature TGFβ 1 to α V β 6 integrin exerts several downstream effects in TGFβ 1 -sensitive cells ( Figure 9 ). One is a marked phosphorylation of p125 FAK . This phosphorylation is dependent on the integrity of the cytoskeleton, as disruption of actin filaments by cytochalasin D completely eliminated this effect, findings which have also been reported for several integrin signaling pathways [66, 67] . Moreover, incubation of the TGFβ 1 sensitive carcinoma cells with TGFβ 1 caused immobilization of the docking protein p130 cas and of the guanine nucleotide exchange factor SOS to the cytoskeleton. Beyond this, a marked induction of the cell cycle inhibitors p21 WAF1 and p27 KIP and a decrease in PCNA expression was detectable.
Finally, TGFβ 1 caused an activation of p21Ras and the MAP kinases ERK1 and ERK2. This TGFβ 1 -induced expression profile was not affected by preincubation of SMAD4 deleted BxPC-3 cells with a TGFβ 1 -RII blocking antibody, which was able to completely block TGFβ 1 -induced SMAD2/3 phosphorylation, thus demonstrating the independence of the TGFβ 1 -signaling from the known SMAD pathway in BxPC-3 cells. In contrast, preincubation with α V -and β 6 -blocking antibodies curbed the TGFβ 1 -induced regulation of p21/WAF1, p27, c-fos, and the p21Ras and ERK1/2 activation, verifying that the binding of TGFβ 1 to the α V β 6 integrin is a prerequisite for the activation of the signal pathway via the α V β 6 integrin. Preincubation of the cells with the MEK1 inhibitor PD98059 Based on our results, we suggest the following model of TGFβ 1 -signaling, which offers an explanation for the different growth responses to TGFβ 1 (Fig. 10 ). In the TGFβ 1 -sensitive cell lines with intact SMAD pathway, the TGFβ 1 response can be attributed to both the common SMAD signaling pathway and the integrin pathway described above. In the cell line BxPC-3, lacking the SMAD4 gene product, the SMAD4-independent pathway can explain the TGFβ 1 sensitivity via α V β 6 integrin, the cytoskeleton and the Ras/MAP kinase pathway, resulting in an upregulation of the cell cycle inhibitiors p21/WAF1 and p27, which in turn results in the TGFβ 1 -induced growth inhibition (additional file 10).
The cell lines Capan-1 and AsPC-1 are not only resistant to TGFβ 1 because of their alterations in the SMAD pathway, but also because they cannot complete the alternate pathway, as demonstrated above. Furthermore, this alternate pathway may explain the TGFβ 1 resistance of cells with no detectable defect in the SMAD pathway [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] , as one can imagine that the cooperative action of the Recombinant mature TGFβ 1 does not contain a RGD motif, and thus binding of TGFβ 1 to the α V β 6 integrin and the subsequent activation of this integrin must rely on a novel motif distinct from RGD. For α V β 6 integrin, a novel non-RGD ligand recognition motif was recently described with the consensus motif DLXXL [120] .
This motif has been detected on several proteins, including laminin, collagen and fibrinogen [120] . A BLAST search for this sequence in TGFβ 1 revealed a 70% similar motif in two parts of the molecule; one in the LAP (data not shown) and one in the mature TGFβ 1 . In mature TGFβ 1 , the DLXXL motif is freely accessible for interactions on the outside of the molecule. Therefore, it may be speculated that TGFβ 1 binding to α V β 6 via this novel ligand recognition motif is facilitating the signaling. Moreover, a non-RGD ligand binding pocket in addition to the usual RGD binding site has been demonstrated for fibrinogen and the α IIb β 3 integrin [121] , supporting our findings.
Conclusions
We demonstrate an alternate TGFβ 1 signaling pathway via α V β 6 integrin, independent of SMAD4. This pathway 
Methods
Cell Culture and TGFβ 1 stimulation
All cells were obtained from from ATCC and maintained in DMEM supplemented with 17% fetal calf serum. Recombinant human proteins (mature TGFβ 1 , TNF-α, Fibronectin and Laminin 1) were purchased from R&D Systems. 10 6 cells were grown overnight in 6 cm diameter dishes with DMEM/10 % FCS. After washing twice with PBS (pH 7.4), fresh DMEM without FCS was added to the monolayer. Cells were stimulated with 10 nM of mature TGFβ 1 or with fibronectin as described below. In blocking experiments, cells were preincubated with either a TGFβ 1 -RII-blocking antibody (R&D Systems # AF-241-NA, 15 µg/ ml for 30 min), α V and β 6 -blocking antibodies (Santa Cruz, sc-6617 and sc-6632 respectively, 1:100 each for 30 min), or the MEK1 inhibitor PD98059 (New England Biolabs # 9900S, 7.5 ng/ml for 10 min) before stimulation with mature TGFβ 1 .
Indirect immunofluorescence
For indirect immunofluorescence, 10 4 cells were cultured on glass coverslips, stimulated with 10 nM mature TGFβ 1 for 10 minutes, stained as described [66, 67] and viewed using a Zeiss LSM-510 confocal microscope. Antibodies used were: actin (sc-8432), TGFβ 1 (sc-146), α V (sc-6617) and β 6 (sc-6632). The following fluorochrome-labeled antibodies were used (AlexaFluor, Molecular Probes):
Activation and nuclear translocation of SMAD2/3 in response to TGFβ 1 (A) Figure 9 Activation and nuclear translocation of SMAD2/3 in response to TGFβ 1 (A). Nuclear and cytoplasmatic fraction of cellular proteins (BxPC-3) after stimulation with 10 nM of TGFβ 1 for 10 minutes and Western blot analysis for SMAD2/3 and phosphorylated SMAD2/3. Purity of cytoplasmic and nuclear fraction (B). Cytoplasmic and nuclear extracts from K562 cells were probed with p125 FAK , PCNA and Iκ Bα antibodies at the same time. As predicted, p125 FAK cold exclusively be detected in the cytoplasmic extract, whereas PCNA is found in the nucleus. Iκ Bα served as loading control. 
Preparation of cytoplasmatic proteins and of nuclei
Cellular fractionation was performed as described in earlier reports [122] [123] [124] [125] . Cells were scraped into 100 µl of ice-cold buffer A [10 mM Hepes (pH 7.9); 1.5 mM MgCl 2 ; 10 mM KCl; 0.5 mM DTT; 0.05% NP-40]. Nuclei were pelleted in a microcentrifuge for 10 sec. at 4°C and 15,000 G.
The supernatant was used to analyze cytoplasmatic proteins, nuclei were resuspended in 60 µl of ice cold buffer B [20 mM Hepes (pH 7.9); 25% (v/v) glycerol; 420 mM KCl; 1.5 mM MgCl 2 ; 0.2 mM EDTA; 0.5 mM DTT; 0.5 mM PMSF] and incubated on ice for 15 min.
Preparation of actin filaments of the cytoskeleton and immunoprecipitation
The cell monolayer was incubated with cell extraction buffer [0.1 % Triton X-100, 80 mM KCl, 20 mM imidazole, 2 mM MgCl 2 , 2 mM EGTA, pH 7.8] for 5 min at 4°C. The Triton-insoluble fractions were then scraped into cold Triton X-100 lysis buffer [50 mM Tris/HCl (pH 7.4); 100 mM NaCl; 50 mM NaF; 5 mM EDTA; 40 mM glycerophosphate; 1 mM sodium orthovanadate; 100 µM PMSF; 1 µM leupeptin; 1 µM pepstatin A; 1% (v/v) Triton X-100] and incubated for 20 min on ice, and clarified by centrifugation at 13000 g for 5 min at 4°C. For immunoprecipitation, the lysates were incubated for 4 h at 4°C with 1 µg of antibody (all from Santa Cruz) preadsorbed on Protein A-Sepharose beads (Pharmacia). Immune complexes were washed five times with cold Triton X-100 lysis buffer. For re-precipitation, the pellet was boiled in 10 µl 0.1% SDS for 5 min and diluted 1:20 in the Triton X lysis buffer followed by the precipitation procedure. All samples were boiled in Laemmli denaturing buffer and analyzed by Western blotting. Whole cell lysates serving as positive controls were prepared by incubating monolayers with denaturing Laemmli buffer.
Treatment with Cytochalasin and Calcium Chelator
To disrupt the actin filaments of the cytoskeleton, the cell monolayer was treated with 25 nM cytochalasin D for 20 min at 37°C; TGFβ 1 was then applied in the presence of 25 nM cytochalasin D. For chelating intracellular calcium, the cells were preincubated with 5 µM of 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, acetoxymethyl ester (BAPTA-AM) for 15 min. TGFβ 1 was then applied in the presence of 5 µM of BAPTA. 
Western Blot
Proteins were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Roche) as described previously [66] . Blot membranes were blocked for 3 h at 37°C in PBS containing 5 % skim milk and probed with the respective antibodies (16 h at 4°C). The following antibodies were used in a dilution of 1:1,000: TGFβ 1 (Santa Cruz [sc], sc-146), p-Tyr (sc-7020), β 6 -integrin (sc-6632), α V -integrin (sc-6617), p125 FAK (sc-557), TGFβ 1 -RI (sc-402), TGFβ 1 -RII (sc-400-G), ERK1/2-P (sc-7383), SMAD2/3 (sc-6033), SOS1/2 (sc-259), p130 cas (UBI-06-500), PCNA (sc-56), p21 WAF1 (sc-6246), p27 KIP (sc-1641), c-fos (sc-7202), c-jun (sc-44), raf1 (sc-133), p21 Ras (sc-35) and phospho-threonine antibody (New England Biolabs, # 9381). Detection antibodies (all from Dako; 1:5,000 for 1 h at room temperature) were mouseanti-goat Ig, mouse-anti-rat Ig, rabbit-anti-mouse Ig, and porcine-anti-rabbit Ig-HRP [66] . To visualize all transferred proteins, we used the ECL protein biotinylation labeling modules (RPN 2202, Amersham) and streptavidin alkaline phosphatase (V020402, Amersham) in accordance with the manufacturer's instructions.
Hypothesis about an alternate TGFβ 1 signaling pathway via α V β 6 integrin, independent of RGD Figure 10 Hypothesis about an alternate TGFβ 1 signaling pathway via α V β 6 integrin, independent of RGD. This pathway may be required for full TGFβ 1 induced transcriptional activation, which explains the TGFβ 1 sensitivity of those cells lacking DPC4/SMAD4 function that still react with growth inhibition. 
Ras
Ras-P Ras
Ras activation assay Only activated p21 Ras is able to bind Raf1, leading to a Raf1-translocation to the cell membrane. After stimulation with 10 nM mature TGFβ 1 for 10 minutes, cells were incubated in sterile water until they lysed. The membrane fraction was lysed in Triton X-100 lysis buffer. Precipitation against Raf1 and analysis for p21 Ras followed.
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